NRIX · Nurix Therapeutics, Inc. · Documents
$26.15
+0.05 (+0.19%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.85B
Shares
109.25M
Volume · Oct 20
3.98M
Avg daily vol (3M)
1.56M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-07-09 | 2021-07-08 | |
| 8-K | — | 2021-06-21 | 2021-06-14 | |
| 8-K | — | 2021-06-02 | — | |
| 8-K | — | 2021-06-01 | 2021-05-28 | |
| 8-K | — | 2021-05-10 | 2021-05-06 | |
| 8-K | — | 2021-04-13 | — | |
| 10-Q | — | 2021-04-13 | 2021-02-28 | |
| DEF 14A | — | 2021-03-25 | 2021-05-06 | |
| 10-K | — | 2021-02-16 | 2020-11-30 | |
| 8-K | — | 2021-02-16 | — | |
| 8-K | — | 2020-12-07 | — | |
| 8-K | — | 2020-10-26 | 2020-10-23 | |
| 8-K | — | 2020-10-14 | — | |
| 8-K | — | 2020-10-14 | — | |
| 10-Q | — | 2020-10-14 | 2020-08-31 |
Showing 101–115 of 115 filings
Key facts
CIK
1549595
CUSIP
67080M103
13F (30d)
12 filings
12 filers
Visit website
Investor relations